Although there are reports that genetic variants of CYP2A6, including whole-gene deletions, are associated with lung cancer risk13, differences in the risk for adenocarcinoma and squamous cell carcinoma of the lungs remain poorly understood. Here, CYP2A6 is linked to adenocarcinoma.